Last month my colleague and I, G.K. Butterfield, introduced the OPEN Act for the second time.
Editor's note · Context
Bilirakis discusses introducing the OPEN Act to incentivize clinical trials for rare diseases.
Share & report
More from Gus Bilirakis
Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise today in strong support of H.R. 1402, the Transparency In Charges for Key Events Ticketing Act, or the TICKET Act. I am proud to lead this bill alongside the…
Mr. Speaker, let me tell you, the speaker on the floor of the House of Representatives in the great State of Florida used to begin his speeches by saying, ``I am fired up.'' I am fired up, Mr. Speaker, because we are going to pass a great…
Mr. Speaker, I move to suspend the rules and pass the bill (S. 146) to require covered platforms to remove nonconsensual intimate visual depictions, and for other purposes. The Clerk read the title of the bill. The text of the bill is as…
Madam Speaker, I ask unanimous consent that all Members may have 5 legislative days in which to revise and extend their remarks and insert extraneous material in the Record for this particular bill. The SPEAKER pro tempore. Is there…





